Nicole Martin
Acute Care · Huntsville, ALNPI 1730645862
Payments from drug & device makers
Across 180 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$436
- AstraZeneca$308
- AbbVie$306
- Pfizer$278
- Neurocrine Biosciences, Inc.$195
- Amgen$163
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,394100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 23 | $436 |
| AstraZeneca(2 entities) | 17 | $308 |
| AbbVie(2 entities) | 14 | $306 |
| Pfizer | 32 | $278 |
| Neurocrine Biosciences, Inc. | 8 | $195 |
| Amgen | 8 | $163 |
| Otsuka America Pharmaceutical, Inc. | 7 | $155 |
| Argenx US, Inc. | 4 | $128 |
| Neurelis, Inc. | 7 | $120 |
| UCB, Inc. | 4 | $112 |
| Bayer | 5 | $102 |
| Mallinckrodt Hospital Products Inc. | 3 | $100 |
| Johnson & Johnson | 3 | $85 |
| ANI Pharmaceuticals, Inc. | 3 | $85 |
| Calliditas Therapeutics US Inc. | 4 | $84 |
| Acadia Pharmaceuticals Inc | 4 | $78 |
| SK Life Science, Inc. | 4 | $67 |
| Merz Pharmaceuticals, LLC | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Genentech USA, Inc. | 2 | $44 |
| C2n Diagnostics, LLC | 2 | $40 |
| Vifor Pharma, Inc. | 2 | $38 |
| OPKO Pharmaceuticals, LLC | 2 | $36 |
| Boehringer Ingelheim | 1 | $31 |
| Eisai Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Grifols USA, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Nxstage Medical, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Akebia Therapeutics Inc | 1 | $21 |
| EMD Serono, Inc. | 1 | $20 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Impel Pharmaceuticals LLC | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Cycle Pharmaceuticals Inc | 1 | $13 |
| Aucta Pharmaceuticals, Inc. | 1 | $6 |
How this compares
$3,394 in reported general payments places this provider in the 85th percentile of 711 acute care providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 22 | $3,813 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 19 | $473 |
| Nifedipine ErNifedipine | 11 | $259 |
| Calcitriol | 19 | $229 |
| Amlodipine Besylate | 31 | $100 |
Paid to pharmacies, not to this prescriber.
Other acute care in Huntsville
- April KlarHuntsville$13K
- Stephanie TateHuntsville$13K
- Kelly VazquezHuntsville$12K
- Summer SlaterHuntsville$12K
- Tiffany RentzHuntsville$11K
- Britanie MooreHuntsville$9K
- Trey WilsonHuntsville$8K
- Esther HambrickHuntsville$8K
- Jessica BurkeenHuntsville$8K
- Alyssa EzellHuntsville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.